Kamila Wierzchowska's research while affiliated with Siedlce University of Natural Sciences and Humanities and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (4)
Staphylococcus aureus is a Gram-positive bacterium, which can cause serious bacterial infections in humans. It constitutes an important etiological factor of many diseases, for instance, soft tissue and skin infections (including skin boils and abscesses), as well as life-threatening necrotizing pneumonia or toxic shock syndrome. It is estimated th...
Objective:
The aim of this study was to determine antimicrobial resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolates from clinical samples from patients hospitalized during 2015 - 2017 in hospitals of Masovian district in Poland.
Materials and methods:
Antimicrobial resistance of 112 MRSA isolates were tested with a...
Analysis of Lamiaceae essential oils (EOs) by GC-FID-MS revealed the presence as the major constituents of linalool (16.8%), linalyl acetate (15.7%) in Lavandula angustifolia, menthol (29.0%), menthone (22.7%), menthyl acetate (19.2%) in Mentha x piperita, terpinen-4-ol (27.1%), (E)-sabinene hydrate (12.1%), γ-terpinene (10.0%) in Origanum majorana...
The aim of this study was to evaluate the ability of 0.1% thyme oil (TO), trans-cinnamaldehyde (TC), ferulic acid (FA), p-coumaric acid (p-CA), caffeic acid (CA), lavender essential oil (LO), geranium essential oil (GO) and tee tree oil (TTO) to control biofilms formed by methicillin-resistant Staphylococcus aureus (MRSA) strains. Depending on the...
Citations
... Há relatos de variados antibióticos que são amplamente utilizados no tratamento de pneumonia, unicamente ou em associações, como ciprofloxacina, eritromicina, gentamicina, entre outros. De acordo com um estudo realizado por Kot et al., (2019), onde um total de 112 amostras foram positivas para MRSA e todos foram submetidos a um teste de sensibilidade antimicrobiana, foi possível identificar resistência a uma diversidade de antibióticos (quadro 2). ...
... At times, the PSMs can affect the sensing system within the bacterial community and thereby inhibit biofilm formation [50][51][52]. Importantly, many secondary metabolites generate ROS that can induce enzymatic oxidative stress responses in a bacterial cell [53,54]. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272448008486937-1441968075784_Q64/Pawel-Czerniewicz.jpg)
... Another study showed an important activity of thyme oil and trans-cinnamaldehyde against MRSA by reducing respectively the biofilms mass 59.7-85% and 52.9-82.4% and biofilm metabolic activity 79.3-86% and 85.9-88.7% after 48 hours treatment at 0.1% concentration (35). The rhodomyrtone a plant-derived principal compound isolated from Rhodomyrtustomentosa (Myrtaceae) leaf extract could be an alternative option for existing antibiotics for the treatment of MRSA infections (36). ...
